# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Higuchi Ichiyō (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI029-SYN
- Date: 2026-04-14
- Fictional facility: St. Posthumous Health Center
- Fictional author: Aiko Lindgren-Tanaka, MD
- Calendar frame: modern shifted

## Reason for visit

New patient visit for seven weeks of cough, fevers, night sweats and weight loss: chest X-ray, sputum specimens, blood tests, airborne precautions, and a report of suspected tuberculosis to the public health center. **S**

## Historical basis

- Higuchi Ichiyō, whose given name was Natsu (also written Natsuko), was born in Tokyo on the 25th day of the 3rd month of Meiji 5 in the Japanese lunisolar calendar, which is 2 May 1872 in the Gregorian calendar, in official housing within the grounds of the Tokyo prefectural office in Uchisaiwai-chō (now in Chiyoda). **D**
- Japan replaced its lunisolar calendar with the Gregorian calendar at the end of Meiji 5: the 3rd day of the 12th month of Meiji 5 became 1 January 1873 (Meiji 6). Dates before then, including her birth, were recorded in the old calendar. **D**
- From 1886 she studied classical poetry (waka) at the Haginoya academy of Nakajima Utako. **D**
- Her father died of illness in the summer of 1889, when she was 17, leaving debts from a failed business; she became head of the household and took on the support of her mother and younger sister, who did washing and needlework, and the family lived in poverty. **D**
- In 1891 she became a pupil of the novelist Nakarai Tōsui and began to write fiction, choosing to earn her living by writing at a time when this was very hard for a woman; her story Umoregi (1892) brought her into the literary world. **D**
- From July 1893 to April 1894 she ran a small shop selling household goods and cheap sweets in Shitaya Ryūsenji-chō, beside the Yoshiwara pleasure quarter (now in Taitō); the shop closed after about ten months, and her life there became material for Takekurabe. **D**
- In May 1894 she moved to Hongō Maruyama-Fukuyama-chō (now Nishikata, Bunkyō). **D**
- At Maruyama-Fukuyama-chō she wrote the works that made her name, among them Ōtsugomori (1894), Nigorie (1895), Takekurabe (1895 to 1896) and Jūsan'ya; Nippon.com calls the period 'the miraculous 14 months', and the Nipponica encyclopedia calls the time up to January 1896 'the miraculous year'. **D**
- From the beginning of 1896 her health declined rapidly. **D**

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- She has coughed for weeks, sweats at night and has lost weight, and fears it is tuberculosis. **S**
- She supports her household by writing and cannot afford to stop working or to pay for many tests. **S**
- She is afraid of passing the illness to the people she lives with and of what neighbors and editors will think. **S**

## Strengths and supports

- Supports and strengths she names: her writing, her readers and editors, and the poetry she studied when young **S**

## Medications and allergies

- No medications before this visit. **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- No historical medical events recorded.

## Procedures and immunizations

- 2026-04-14 to 2026-04-14: Chest X-ray, two views: patchy opacities in the apical and posterior segments of the right upper lobe with small nodules; no cavity, effusion or hilar enlargement **S**


## Family history

- father: Died of illness in 1889; cause not recorded in the cited source **D** (CLM-0004)

## Measurements

Hemoglobin: 11.4 g/dL (low); White cell count: 8.6 10*3/uL; Platelets: 452 10*3/uL (high); ALT: 12 U/L; AST: 19 U/L; Total bilirubin: 0.4 mg/dL; Alkaline phosphatase: 74 U/L; Albumin: 3.3 g/dL (low); Creatinine: 0.56 mg/dL; eGFR: 131 mL/min/1.73 m²; Glucose: 82 mg/dL; Hemoglobin A1c: 5.1%; Visual acuity, right eye (ETDRS letters): 85; Visual acuity, left eye (ETDRS letters): 85; PHQ-9: 8; AUDIT-C: 0. All results are synthetic.

BP 98/62 mmHg; pulse 104 bpm; respirations 20/min; temperature 37.8 °C; oxygen saturation 96% on room air; weight 38.5 kg; BMI 17.6 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, composed and precise in her answers, with a wry humor; thin and tired; organized thought; Mood worried about money, her household and her deadlines; PHQ-9 8, with item 9 scored 0; no thoughts of suicide or self-harm. Functional status: Independent; too tired over the past month to write for more than an hour or two, and short of breath on the stairs. Physical examination is intentionally limited. **S**

## Assessment

1. Cough for about seven weeks with evening fevers, night sweats, poor appetite and weight loss of about 4 kg (about 10 percent) in a woman of 23; chest X-ray with patchy right upper lobe opacities and no cavity; suspected pulmonary tuberculosis; airborne precautions and three sputum specimens for acid-fast smear, nucleic acid amplification and culture; status draft. **S**
2. Moderate protein-calorie malnutrition: BMI 17.6, about 10 percent weight loss in two months, and albumin 3.3 g/dL; status draft. **S**
3. Low and irregular income from writing, with a household to support; costs of care are a barrier; status draft. **S**

## Plan

- Diagnosis and safety: chest X-ray; three sputum specimens at least eight hours apart, one early in the morning, for acid-fast smear, Xpert MTB/RIF Ultra, liquid and solid culture and drug susceptibility testing; HIV, hepatitis B and hepatitis C tests and a pregnancy test; blood count, liver and kidney tests, glucose and hemoglobin A1c; visual acuity and color vision before ethambutol. Guideline: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016); WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment (2022); Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children (2017) **S**
- Infectious diseases consultation at the results visit to confirm the diagnosis, choose between the six-month and four-month regimens, set the doses for her weight, and plan monitoring and infection control. Guideline: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016); Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline (2025); Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022 (2022) **S**
- Infection control and public health: airborne precautions in the clinic; at home, no visitors, a surgical mask in shared rooms, windows open, and sleeping in her own room until the public health center confirms she is no longer infectious; report of suspected tuberculosis to the public health center the same day and notification at once on diagnosis; a contact investigation of her household and other close contacts led by the public health center. Guideline: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016); Guidelines for the investigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and CDC (2005); 結核 (Tuberculosis): notification criteria under Article 12 of the Infectious Diseases Control Law (current) **S**
- Nutrition, income and writing: two dietitian visits in the first month, three meals and two energy-dense snacks a day with two oral nutrition supplement drinks, and weight at every visit; a medical social worker to apply for public funding of tuberculosis treatment and to review other help with costs; a paced writing plan of short sessions in daylight with rest; PHQ-9 at intake, at two months and at the end of treatment. Guideline: 結核医療費の公費負担 (Public funding of tuberculosis medical costs under Articles 37 and 37-2 of the Infectious Diseases Control Law) (current); Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition) (2012); Depression and Suicide Risk in Adults: Screening (2023) **S**

## Guideline basis

- Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016), American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America (Clinical Infectious Diseases 2016;63(7):e147-e195)
- Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline (2025), American Thoracic Society, Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America (American Journal of Respiratory and Critical Care Medicine 2025;211(1):15-33)
- WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment (2022), World Health Organization
- Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children (2017), American Thoracic Society, Infectious Diseases Society of America, and Centers for Disease Control and Prevention (Clinical Infectious Diseases)
- Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022 (2022), Centers for Disease Control and Prevention (MMWR)
- Guidelines for the investigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and CDC (2005), Centers for Disease Control and Prevention (MMWR Recommendations and Reports)
- 結核 (Tuberculosis): notification criteria under Article 12 of the Infectious Diseases Control Law (current), Ministry of Health, Labour and Welfare, Japan
- 結核医療費の公費負担 (Public funding of tuberculosis medical costs under Articles 37 and 37-2 of the Infectious Diseases Control Law) (current), Niigata Prefecture, Japan
- Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition) (2012), Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition (JPEN)
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
